C.F.R. homeSearch C.F.R.
C.F.R.Title 49Part 40—Procedures for Transportation Workplace Drug and Alcohol Testing ProgramsSubpart F—Drug Testing Laboratories

49 C.F.R. § 40.87 (2026)

What validity tests must laboratories conduct on primary urine specimens?

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 ACTIVE · 3 IN 5Y cited 2002–2026 9citing cases
At a glance

Courts have cited this section in 9 opinions since 2002, 3 of them in the last five years. The most litigated part is subsection (a) (1 case).

As a laboratory, when you conduct validity testing under § 40.86, you must conduct it in accordance with the requirements of this section.

(a) You must determine the creatinine concentration on each primary specimen. You must also determine its specific gravity if you find the creatinine concentration to be less than 20 mg/dL.

(b) You must determine the pH of each primary specimen.

(c) You must perform one or more validity tests for oxidizing adulterants on each primary specimen.

(d) You must perform additional validity tests on the primary specimen when the following conditions are observed:

(1) Abnormal physical characteristics;

(2) Reactions or responses characteristic of an adulterant obtained during initial or confirmatory drug tests (e.g., non-recovery of internal standards, unusual response); or

(3) Possible unidentified interfering substance or adulterant.

(e) If you determine that the specimen is invalid and HHS guidelines direct you to contact the MRO, you must contact the MRO and together decide if testing the primary specimen by another HHS certified laboratory would be useful in being able to report a positive or adulterated test result.

[65 FR 79526, Dec. 19, 2000, as amended at 69 FR 64867, Nov. 9, 2004. Redesignated and amended at 88 FR 27643, May 2, 2023]
The 9 cases that cite 49 C.F.R. § 40.87 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENRodriguez v. Lab'y Corp. of Am. Holdings, 13 F. Supp. 3d 121 (D.C. Cir. 2014).
cites § 40.87 2×cited by 17 cases
Where it cites § 40.87
“4; see also 49 C.F.R. § 40.87 . To conduct the initial screen, the laboratory must use an enzyme-multiplied immunoassay technique (“EMIT”) test.”
Later courts cite it for
“because fraud claims are subject to a heightened pleading standard under rule 9(b) of the federal rules of civil procedure, a plaintiff 'must state the time, place and content of the . false misrepresentations, the fact misrepresented and what was obtained or given up as a consequence of the fraud.” · 3 citing courts
2
GREENRector v. LabOne, Inc., 208 F. Supp. 2d 987 (E.D. Ark. 2002).
cites § 40.87 1×cited by 6 cases
Where it cites § 40.87
“See 49 C.F.R. § 40.87 . The laboratory then reports the result to the Medical Review Officer.”
3
GREENGabbard v. Fed. Aviation Admin., 532 F.3d 563 (6th Cir. 2008).
cites § 40.87 1×cited by 2 cases
Where it cites § 40.87
“See 49 C.F.R. § 40.87 . Gabbard flew a chartered jet at 1:10 p.”
4
NEUTRALTownley v. Georgia Pac. Corp., 388 S.W.3d 475 (Ark. Ct. App. 2012).
cites § 40.87 3×cited by 2 cases
Where it cites § 40.87
“49 C.F.R. § 40.87 (a). The initial test cutoff concentration for marijuana metabolites is 50 ng/mL, and the confirmatory test cutoff concentration is 15 ng/mL.”
5
GREENClucas v. RT 80 Express, Inc., 2012-Ohio-1259.
cites § 40.87 1×subsections: (a)cited by 1 case
Where it cites § 40.87
“He does not dispute the accuracy of the measurement; instead, he argues that any result less than 50 ng/ml must be deemed a negative result pursuant to 49 C.F.R. 40.87(a). Section 40 of the Code of Federal Regulations distinguishes between Department of Transportation drug and…”
6
GREENMichael Anderson v. Detroit Transit Co., 435 F. Supp. 3d 783 (E.D. Mich. 2020).
cites § 40.87 3×cited by 0 casesunknown
Where it cites § 40.87
“) Anderson’s tests results were above the drug test thresholds contained in 49 C.F.R. § 40.87 , but Defendants omitted significant qualifiers in their explanations.”
7
NO FLAGJohnson v. HireRight, LLC, No. 4:22-cv-00270 (N.D. Okla. July 21, 2023).
cites § 40.87 1×cited by 0 casesunknown
Where it cites § 40.87
“On initial testing, Plaintiff’s specimen screened positive for THCA at a level of 74 ng/mL Because Plaintiff’s THCA levels exceeded the federally defined cutoff of 50 ng/mL, the specimen was sent for definitive confirmation testing pursuant to 49 C.F.R. § 40.87 (b). The…”
8
NO FLAGIn the Matter of P.O. Stephen McGee, Etc., No. A-0566-22 (N.J. Super. Ct. App. Div. Oct. 4, 2024).
cites § 40.87 1×cited by 0 casesunpublished
Where it cites § 40.87
“He noted McGee's primary specimen was twice tested A-0566-22 22 above both established thresholds under 49 C.F.R. 40.87. First, it was tested at 51 ng/ml, above the 50 ng/ml threshold, then it was tested to confirm a threshold above 15 ng/ml.”
9
NEUTRALDel Rosario v. Fresh Mark, Inc., 2026-Ohio-274.
cites § 40.87 1×cited by 0 cases
Where it cites § 40.87
“87 of Title 49 of the Code of Federal Regulations, 49 C.F.R. 40.87, as amended." The burden of proof to overcome the rebuttal presumption is on the claimant.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
200220142026

One bar per year. Tallest: 2 cases in 2012. 2026 is a partial year. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
Ohio Ct. App.2E.D. Ark.1Ark. Ct. App.16th Cir.1D.C. Cir.1E.D. Mich.1N.J. Super. Ct. App. Div.1N.D. Okla.1
By subsection
(a)1 case
Clucas v. RT 80 Express, Inc., 2012-Ohio-1259.“He does not dispute the accuracy of the measurement; instead, he argues that any result less than 50 ng/ml must be deemed a negative result pursuant to 49 C.F.R. 40.87(a). Section 40 of the Code of Federal Regulations distinguishes between Department of Transportation drug and…”
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com